126 related articles for article (PubMed ID: 12044883)
1. Ascorbate inhibits iNOS expression in endotoxin- and IFN gamma-stimulated rat skeletal muscle endothelial cells.
Wu F; Tyml K; Wilson JX
FEBS Lett; 2002 Jun; 520(1-3):122-6. PubMed ID: 12044883
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide attenuates but superoxide enhances iNOS expression in endotoxin- and IFNgamma-stimulated skeletal muscle endothelial cells.
Wu F; Cepinskas G; Wilson JX; Tyml K
Microcirculation; 2001 Dec; 8(6):415-25. PubMed ID: 11781814
[TBL] [Abstract][Full Text] [Related]
3. Molecular role of ascorbate in enhancement of NO production in activated macrophage-like cell line, J774.1.
Mizutani A; Tsukagoshi N
J Nutr Sci Vitaminol (Tokyo); 1999 Aug; 45(4):423-35. PubMed ID: 10575633
[TBL] [Abstract][Full Text] [Related]
4. Sepsis inhibits reduction of dehydroascorbic acid and accumulation of ascorbate in astroglial cultures: intracellular ascorbate depletion increases nitric oxide synthase induction and glutamate uptake inhibition.
Korcok J; Wu F; Tyml K; Hammond RR; Wilson JX
J Neurochem; 2002 Apr; 81(1):185-93. PubMed ID: 12067232
[TBL] [Abstract][Full Text] [Related]
5. Ascorbate inhibits iNOS expression and preserves vasoconstrictor responsiveness in skeletal muscle of septic mice.
Wu F; Wilson JX; Tyml K
Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R50-6. PubMed ID: 12637347
[TBL] [Abstract][Full Text] [Related]
6. Ascorbate enhances iNOS activity by increasing tetrahydrobiopterin in RAW 264.7 cells.
Nakai K; Urushihara M; Kubota Y; Kosaka H
Free Radic Biol Med; 2003 Oct; 35(8):929-37. PubMed ID: 14556857
[TBL] [Abstract][Full Text] [Related]
7. p38 Mitogen-activated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-gamma through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells.
Huang H; Rose JL; Hoyt DG
Mol Pharmacol; 2004 Aug; 66(2):302-11. PubMed ID: 15266021
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages.
Han YJ; Kwon YG; Chung HT; Lee SK; Simmons RL; Billiar TR; Kim YM
Nitric Oxide; 2001; 5(5):504-13. PubMed ID: 11587565
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.
Kobayashi O; Miwa H; Watanabe S; Tsujii M; Dubois RN; Sato N
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G688-96. PubMed ID: 11518681
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ.
Wagner AH; Schwabe O; Hecker M
Br J Pharmacol; 2002 May; 136(1):143-9. PubMed ID: 11976279
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB mediates simultaneous induction of inducible nitric-oxide synthase and Up-regulation of the cationic amino acid transporter CAT-2B in rat alveolar macrophages.
Hammermann R; Dreissig MD; Mössner J; Fuhrmann M; Berrino L; Göthert M; Racké K
Mol Pharmacol; 2000 Dec; 58(6):1294-302. PubMed ID: 11093766
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolic acid inhibits activation of inducible nitric oxide synthase in rodent fibroblasts.
Miljkovic Dj; Cvetkovic I; Stosic-Grujicic S; Trajkovic V
Clin Exp Immunol; 2003 May; 132(2):239-46. PubMed ID: 12699411
[TBL] [Abstract][Full Text] [Related]
13. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription.
Saura M; Zaragoza C; Bao C; McMillan A; Lowenstein CJ
J Mol Biol; 1999 Jun; 289(3):459-71. PubMed ID: 10356322
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production.
Flodström M; Eizirik DL
Endocrinology; 1997 Jul; 138(7):2747-53. PubMed ID: 9202213
[TBL] [Abstract][Full Text] [Related]
15. KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis.
Inoue T; Hamada Y; Takeshita K; Fukushima K; Higaki M
J Rheumatol; 2001 Jun; 28(6):1229-37. PubMed ID: 11409114
[TBL] [Abstract][Full Text] [Related]
16. Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-kappaB.
Iuvone T; D'Acquisto F; Van Osselaer N; Di Rosa M; Carnuccio R; Herman AG
Br J Pharmacol; 1998 Apr; 123(7):1325-30. PubMed ID: 9579726
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acids inhibit inducible nitric oxide synthase expression in mesangial cells.
Datta PK; Lianos EA
Kidney Int; 1999 Aug; 56(2):486-93. PubMed ID: 10432387
[TBL] [Abstract][Full Text] [Related]
19. Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells.
Hattori Y; Nakanishi N; Kasai K
Cardiovasc Res; 2002 Jun; 54(3):649-58. PubMed ID: 12031711
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester synergistically increases interferon regulatory factor-1 and inducible nitric oxide synthase induction in interferon-gamma-treated RAW 264.7 cells.
Momose I; Terashima M; Nakashima Y; Sakamoto M; Ishino H; Nabika T; Hosokawa Y; Tanigawa Y
Biochim Biophys Acta; 2000 Oct; 1498(1):19-31. PubMed ID: 11042347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
